CellTracker Red CMTPX

Catalog No. :
ACVVNF642
CAS No. :
942416-35-5
Molecular Formula :
C84H80Cl2N6O8
Molecular Weight :
1372.50

IUPAC Name:4-(4-(chloromethyl)benzamido)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g']diquinolin-1-ium-6-yl)benzoate--5-(4-(chloromethyl)benzamido)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g']diquinolin-1-ium-6-yl)benzoate (1/1)

CellTracker Red CMTPX structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCellTracker Red CMTPX
IUPAC Name4-(4-(chloromethyl)benzamido)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g']diquinolin-1-ium-6-yl)benzoate--5-(4-(chloromethyl)benzamido)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g']diquinolin-1-ium-6-yl)benzoate (1/1)
Molecular FormulaC84H80Cl2N6O8
Molecular Weight1372.50
SMILESCC1=CC(C)(C)N(C)C2=CC3=C(C=C12)C(C1=CC(NC(=O)C2=CC=C(CCl)C=C2)=CC=C1C(=O)[O-])=C1C=C2C(C)=CC(C)(C)[N+](C)=C2C=C1O3.CC1=CC(C)(C)N(C)C2=CC3=C(C=C12)C(C1=CC=C(NC(=O)C2=CC=C(CCl)C=C2)C=C1C(=O)[O-])=C1C=C2C(C)=CC(C)(C)[N+](C)=C2C=C1O3
InChI KeyDGFDEYIVGMCAPY-UHFFFAOYSA-N
SynonymCytoTrace Red CMTPX
CAS No.942416-35-5

Synthetic Route by SureRoute

1. ACVVNF642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVVNF642 route product structure diagram
    ACVVNF642942416-35-5
Inquiry

2. ACVVNF642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVVNF642 route product structure diagram
    ACVVNF642942416-35-5
Inquiry

Comments (0)